A Study of High-Dose Trivalent Inactivated Influenza Vaccine in Adults 50 to 64 Years of Age

NCT01258595 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: High-Dose Trivalent Inactivated Influenza Vaccine
BIOLOGICAL: Trivalent Inactivated Influenza Vaccine

Sponsor

Sanofi Pasteur, a Sanofi Company